000			01614 a2200385 4500
005			20250512025412.0
264		0	_c19861217
008			198612s 0 0 eng d
022			_a0027-8424
024	7		_a10.1073/pnas.83.22.8764 _2doi
040			_aNLM _beng _cNLM
100	1		_aSchally, A V
245	0	0	_aCombination of a long-acting delivery system for luteinizing hormone-releasing hormone agonist with Novantrone chemotherapy: increased efficacy in the rat prostate cancer model. _h[electronic resource]
260			_bProceedings of the National Academy of Sciences of the United States of America _cNov 1986
300			_a8764-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCapsules
650	0	4	_aDelayed-Action Preparations
650	0	4	_aDisease Models, Animal
650	0	4	_aGonadotropin-Releasing Hormone _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMitoxantrone _xadministration & dosage
650	0	4	_aProstatic Neoplasms _xdrug therapy
650	0	4	_aRats
650	0	4	_aRats, Inbred Strains
650	0	4	_aTriptorelin Pamoate
700	1		_aKook, A I
700	1		_aMonje, E
700	1		_aRedding, T W
700	1		_aPaz-Bouza, J I
773	0		_tProceedings of the National Academy of Sciences of the United States of America _gvol. 83 _gno. 22 _gp. 8764-8
856	4	0	_uhttps://doi.org/10.1073/pnas.83.22.8764 _zAvailable from publisher's website
999			_c2951890 _d2951890